Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Kalamazoo
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kalamazoo, MI

Studies commonly pay $75 to $4,500 per completed study

102 clinical trials are currently recruiting participants within 30 miles of Kalamazoo. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

102studies recruiting
7+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Kalamazoo right now

Top 25 of 102 recruiting studies, sorted by proximity — each links to its official registry page

Combining a Smartphone App With Medications to Manage Heavy Drinking

Alcohol Use Disorder (AUD) N/A Interventional 330 participants sought
Battle Creek VA Medical Center, Battle Creek, MI — Battle Creek, Michigan (21.2 mi) · Sponsor: VA Office of Research and Development
See eligibility & contact on ClinicalTrials.gov (NCT06303778)

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Lung Non-Small Cell Carcinoma Phase 3 Interventional 336 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07388524)

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03959085)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
WMU Homer Stryker MD School of Medicine — Kalamazoo, Michigan (1.2 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum N/A Interventional 9,500 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05080673)

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm N/A Observational 5,000 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute LAO
See eligibility & contact on ClinicalTrials.gov (NCT02474160)

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Cutaneous Melanoma, Stage II N/A Interventional 2,998 participants sought
West Michigan Cancer Centre — Kalamazoo, Michigan (1.2 mi) · Sponsor: Melanoma and Skin Cancer Trials Limited
See eligibility & contact on ClinicalTrials.gov (NCT03860883)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 Phase 3 Interventional 486 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07097142)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

End Stage Kidney Disease Phase 2, Phase 3 Interventional 3,110 participants sought
Paragon Health, Inc — Kalamazoo, Michigan (1.2 mi) · Sponsor: CSL Behring
See eligibility & contact on ClinicalTrials.gov (NCT05485961)

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Colorectal Cancer Stage II, Colorectal Cancer Stage III Phase 3 Interventional 1,057 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT07018869)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02402244)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Acute Treatment of Migraine Phase 3 Interventional 600 participants sought
Wellnow Urgent Care and Research — Kalamazoo, Michigan (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04743141)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma Phase 2, Phase 3 Interventional 992 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05987241)

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes N/A Observational 10,000 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: Dana-Farber Cancer Institute
See eligibility & contact on ClinicalTrials.gov (NCT02269592)

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Phase 2 Interventional 112 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04511013)

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma Phase 2, Phase 3 Interventional 189 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05058651)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Multiple conditions Phase 2 Interventional 150 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05136196)
Actively enrolling

Studies you may be able to join near Kalamazoo

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Kalamazoo

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Center for Clinical Research at WMed

★ 5.0 (1 reviews)
1000 Oakland Dr, Kalamazoo, MI 49008
(269) 337-4264
"I would like overnight clinic study paid. Kalamazoo"
— Terri Dee Little, 5★

Center For Clinical Research Solutions

★ 5.0
321 S Kalamazoo Mall #214, Kalamazoo, MI 49007
(269) 488-5947

West Michigan Cancer Center

★ 4.9 (1299 reviews)
200 N Park St, Kalamazoo, MI 49007
(269) 382-2500
"Individuals that work here are informative and care about their patients."
— Kenneth Randt, 5★

West Michigan Clinical Research Center

2093 Health Dr SW Ste 201, Wyoming, MI 49519
(616) 328-5344

WMed Innovation Center

★ 5.0
4717 Campus Dr, Kalamazoo, MI 49008
(269) 353-1823

Lighthouse Autism Center - Kalamazoo

★ 3.3 (8 reviews)
4625 W KL Ave, Kalamazoo, MI 49006
(269) 249-1490
"Lighthouse helped my child be comfortable with herself and offered her support and fun ways to tackle challenges. The staff are all wonderful and de…"
— Angel Raatz, 5★

Kalamazoo Autism Center

★ 4.5 (8 reviews)
4200 S Westnedge Ave, Kalamazoo, MI 49008
(269) 459-7821
"My son attended the autism center for 2 years. During that time I cannot recall one issue with the Kalamazoo Autism Center. This was the most seamles…"
— Kyria, 5★

Clinical trials in Kalamazoo: what's recruiting

The Kalamazoo area currently has 102 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kalamazoo, the most active research areas are:

  • Cancer & Oncology19 studies
  • Liver & Kidney3 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Kalamazoo, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kalamazoo

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kalamazoo participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Kalamazoo pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Kalamazoo safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Kalamazoo, MI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Kalamazoo?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kalamazoo typically complete one or two studies per year.

Paid clinical trials near Kalamazoo

Other metros within reach

Grand Rapids, MI465 Elkhart, IN105 South Bend, IN105 Lansing, MI170 Muskegon, MI65 Fort Wayne, IN117 Ann Arbor, MI1,177 South Lyon, MI1,324

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Kalamazoo Bladder Issues Due To Spinal Cord Injury in Kalamazoo All conditions

More of MI

South Lyon1,324 Detroit1,198 Ann Arbor1,177 Grand Rapids465 Lansing170 Flint167 Muskegon65

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts